BioArctic AB's (publ) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion for the ...

In October 2024, the TGA made the decision not to register lecanemab in Australia for the treatment of patients with early AD. In December 2024, Eisai requested reconsideration of the decision, ...

BioArctic AB's (publ) (NASDAQ: BIOA B) (STOCKHOLM: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) ...

Scholar Rock Holding Corporation. ( NASDAQ: SRRK) Q4 2024 Earnings Conference Call February 27, 2025 8:15 AM ET Jay Backstrom - President & CEO Ted Myles - COO & CFO Tracey Sacco - Chief Commercial ...

Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...

The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a breast cancer ...

European Union leaders have backed plans to spend more on defence amid growing uncertainty over United States President Donald Trump’s support for the continent’s security. In recent weeks ...

The meeting takes place against a backdrop of dramatic defence policy decisions driven by fears that Russia, emboldened by its war in Ukraine, may attack an EU country next and that Europe cannot ...

BRUSSELS — The European Union on Feb. 27 pushed back hard against allegations by ... vigorously fight any wholesale tariff of 25% on all EU products. The tit-for-tat dispute following the ...

The decisions announced by the EU Tuesday were directly caused by member ... Iannopollo said that she expects to see those come back in a revised form. “I don’t think this is a final call.